Composition comprising humanized antibody HBBK4 for the treatment of cancer and the use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 9, 2010
Grant Date -
Feb 12, 2009
app pub date -
May 24, 2006
filing date -
May 24, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention is related to a pharmaceutical composition comprising humanized anti-4-1BB antibody (HBBK4) for treating cancer by inducing increase of CD11+CD8+ T cell and IFN-γ, and inhibiting proliferation of cancer cells, together with a pharmaceutically acceptable carrier and the use. Accordingly, it can be useful in the prevention or treatment of cancer without adverse response.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully